Login
Companies $TMDX
$91.86 -$0.35 (0.38%) After hours
TransMedics Group, Inc. logo

TransMedics Group, Inc.

transmedics.com

What Do They Do?

Builds portable systems that preserve and assess donor hearts, lungs and livers, and provides organ-procurement, perfusion-management and transport services to transplant centers.

How Do They Make Money?

Transplant centers buy single-use sets for transplant procedures, consoles, and NOP procurement, perfusion-management and logistics services. Revenue from each product or service is earned when it is delivered.

FY2025 revenue by product or service revenue
SegmentShareRevenue
Cost of net product revenue
Sold outright

62%
FY2022: 85%
Cost of service revenue
Sold outright

39%
FY2022: 15%

Who Are Their Customers?

Transplant centers are end customers worldwide: U.S. centers can outsource procurement and logistics through the NOP or buy OCS products directly and train their own teams. A small portion of sales goes through distributors in Europe and Asia-Pacific.

Do Revenues Turn Into Profits?

Yes. It kept 31 cents of every revenue dollar as net income in FY2025 and turned 22 cents into free cash flow.

Operating income, FY2025
18% of revenue
▲ +190% vs FY2024 ($37.5M, 8%)
Net income, FY2025
31% of revenue
▲ +437% vs FY2024 ($35.5M, 8%)
Free cash flow, FY2025
22% of revenue
▲ Turned profitable vs FY2024 (−$80.9M, −18%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +41%
vs $143.8M in Q3 FY2025
Net income
▼ −30%
vs $24.3M in Q3 FY2025
Net product revenue share of revenue vs 61.0% in Q3 FY2025
  • Sep 10, 2026 Appointed a new CFO and reiterated 2026 revenue guidance Fernando Araujo succeeds Gerardo Hernandez; the outlook remains $737 million to $757 million.
  • Aug 4, 2026 Raised the low end of 2026 revenue guidance The range became $737 million to $757 million, excluding revenue from PAD Aviation.

Growing. Revenue grew 20.0x in 4 years, from $30.3M in FY2021 to $605.5M in FY2025, about 111% a year.

Expanded NOP logistics The NOP has grown from an outsourced organ-retrieval and OCS-management service into an offering that also coordinates aviation and ground transport, including dedicated aircraft.

Added a kidney product in development The older report described development for additional organs generally; the latest report identifies a kidney product in development that will use the newer multi-organ platform.

Added European logistics activity The older report described European distribution and commercial operations; the latest report also describes building logistics support for the NOP in European regions.

Revenue over time
Cost of net product revenue Cost of service revenue
$1B$500M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support